227 reports of this reaction
1.2% of all OSELTAMIVIR reports
#20 most reported adverse reaction
GENERAL PHYSICAL HEALTH DETERIORATION is the #20 most commonly reported adverse reaction for OSELTAMIVIR, manufactured by Amneal Pharmaceuticals NY LLC. There are 227 FDA adverse event reports linking OSELTAMIVIR to GENERAL PHYSICAL HEALTH DETERIORATION. This represents approximately 1.2% of all 19,111 adverse event reports for this drug.
Patients taking OSELTAMIVIR who experience general physical health deterioration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
GENERAL PHYSICAL HEALTH DETERIORATION is a less commonly reported adverse event for OSELTAMIVIR, but still significant enough to appear in the safety profile.
In addition to general physical health deterioration, the following adverse reactions have been reported for OSELTAMIVIR:
The following drugs have also been linked to general physical health deterioration in FDA adverse event reports:
GENERAL PHYSICAL HEALTH DETERIORATION has been reported as an adverse event in 227 FDA reports for OSELTAMIVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.
GENERAL PHYSICAL HEALTH DETERIORATION accounts for approximately 1.2% of all adverse event reports for OSELTAMIVIR, making it a notable side effect.
If you experience general physical health deterioration while taking OSELTAMIVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.